Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

U Hamid; A Krasnodembskaya; M Fitzgerald; M Shyamsundar; A Kissenpfennig; C Scott; E Lefrancais; M Looney; R Verghis; J Scott; A Simpson; J Mcnamee; D Mcauley; C O'Kane

doi:10.1136/thoraxjnl-2016-208571

Journal articles

Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

U Hamid ¹ A Krasnodembskaya M Fitzgerald M Shyamsundar A Kissenpfennig C Scott E Lefrancais ² M Looney R Verghis J Scott A Simpson J Mcnamee D Mcauley C O'Kane

1 QUB - Queen's University [Belfast]

2 UCSF - Department of Medicine, Microbiology and Immunology

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Human health and pathology / Pulmonology and respiratory tract

Life Sciences [q-bio] / Immunology / Innate immunity

Life Sciences [q-bio] / Biochemistry, Molecular Biology

Life Sciences [q-bio] / Human health and pathology / Tissues and Organs [q-bio.TO]

Complete list of metadata

https://hal-cnrs.archives-ouvertes.fr/hal-02997990
Contributor : Emma Lefrancais Connect in order to contact the contributor
Submitted on : Tuesday, November 10, 2020 - 12:30:37 PM
Last modification on : Thursday, November 18, 2021 - 9:18:20 AM

Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

Links full text

Identifiers

Collections

Citation

Export

Metrics

9

Aspirin reduces lipopolysaccharide-induced pulmonary inflammation in human models of ARDS

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

9